NCT00464256View on ClinicalTrials.gov

Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking Cessation

PHASE3CompletedINTERVENTIONAL

Enrollment

533

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions

Smoking Cessation

Interventions

DRUG

rimonabant

Trial Locations (1)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY